SE424991B - Sett att framstella nya 5-fenyl-oxazolidinoner - Google Patents
Sett att framstella nya 5-fenyl-oxazolidinonerInfo
- Publication number
- SE424991B SE424991B SE7609426A SE7609426A SE424991B SE 424991 B SE424991 B SE 424991B SE 7609426 A SE7609426 A SE 7609426A SE 7609426 A SE7609426 A SE 7609426A SE 424991 B SE424991 B SE 424991B
- Authority
- SE
- Sweden
- Prior art keywords
- oxazolidinones
- phenyl
- make new
- new
- make
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2538424A DE2538424C2 (de) | 1975-08-29 | 1975-08-29 | 4-substituierte 5-Phenyl-oxazolidon-(2)- Verbindungen und ein diese enthaltendes pharmazeutisches Präparat |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7609426L SE7609426L (sv) | 1977-03-01 |
SE424991B true SE424991B (sv) | 1982-08-23 |
Family
ID=5955093
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7609426A SE424991B (sv) | 1975-08-29 | 1976-08-25 | Sett att framstella nya 5-fenyl-oxazolidinoner |
Country Status (22)
Country | Link |
---|---|
US (1) | US4139538A (sv) |
JP (1) | JPS5253857A (sv) |
AT (1) | AT347453B (sv) |
AU (1) | AU506441B2 (sv) |
BE (1) | BE845581A (sv) |
CA (1) | CA1072567A (sv) |
CH (1) | CH623043A5 (sv) |
DE (1) | DE2538424C2 (sv) |
DK (1) | DK387876A (sv) |
FI (1) | FI62074C (sv) |
FR (1) | FR2321884A1 (sv) |
GB (1) | GB1555658A (sv) |
HU (1) | HU174488B (sv) |
IE (1) | IE43396B1 (sv) |
IL (1) | IL50091A (sv) |
IN (1) | IN144061B (sv) |
LU (1) | LU75659A1 (sv) |
NL (1) | NL7609559A (sv) |
NO (1) | NO143316C (sv) |
PL (1) | PL100901B1 (sv) |
SE (1) | SE424991B (sv) |
ZA (1) | ZA764279B (sv) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179442A (en) * | 1975-08-29 | 1979-12-18 | York Hartleben | 4-(Alpha-hydroxy-isopropyl)-5-phenyl-oxazolidin-2-one |
LU80081A1 (fr) * | 1977-08-26 | 1979-05-15 | Delalande Sa | Nouvelles hydroxymethyl-5 oxazolidinones-2,leur procede de preparation et leur application therapeutique |
EP0008711B1 (en) * | 1978-08-15 | 1981-11-04 | Smithkline Beckman Corporation | A method of preparing a 2-hydroxy-3-isopropyl or a 2-hydroxy-3-tert-butylaminopropyl aromatic ether |
US5105009A (en) * | 1983-06-02 | 1992-04-14 | Zambon S.P.A. | Intermediates for the preparation of 1-(phenyl)-1-hydroxy-2-amino-3-fluoropropane derivatives |
US5623087A (en) * | 1995-03-10 | 1997-04-22 | Ndsu-Research Foundation | Method for preparation of optically active diarylalanines |
GB9826700D0 (en) * | 1998-12-05 | 1999-01-27 | Univ Durham | Process for preparing chiral compounds |
US20020019539A1 (en) | 2000-03-31 | 2002-02-14 | Bailey Anne E. | Process for the preparation of matrix metalloproteinase inhibitors |
WO2001074792A2 (en) * | 2000-03-31 | 2001-10-11 | Abbott Laboratories | Process for the preparation of matrix metalloproteinase inhibitors |
FR2832613B1 (fr) * | 2001-11-27 | 2004-02-13 | Seb Sa | Panier de cuisson d'aliments pour autocuiseur, autocuiseur destne a recevoir un panier de cuisson et procede de fabrication d'un panier de cuisson d'aliments par emboutissage |
JP2010503656A (ja) | 2006-09-13 | 2010-02-04 | アストラゼネカ アクチボラグ | スピロ−オキサゾリジノン化合物と代謝共役型グルタミン酸受容体ポテンシエーターとしてのその使用 |
KR20150075091A (ko) * | 2012-10-29 | 2015-07-02 | 에프. 호프만-라 로슈 아게 | 3,4-이치환된 옥사졸리디논 유도체 및 칼슘 활성화 칼륨 채널의 억제제로서 이의 용도 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1302662B (sv) * | 1971-02-04 | |||
US2399118A (en) * | 1942-02-13 | 1946-04-23 | Mallinckrodt Chemical Works | 2-oxazolidone compounds and method for preparing the same |
DE1157627B (de) * | 1957-08-28 | 1963-11-21 | Robins Co Inc A H | Verfahren zur Herstellung von 5-(o-Alkoxyphenoxymethyl)-oxazolidonen-(2) |
DE1130131B (de) * | 1957-11-08 | 1962-05-24 | Eugen Bellmann G M B H Maschf | Bundkippzange |
BE585502A (fr) | 1958-12-09 | 1960-06-09 | American Cyanamid Co | Composes hétérocycliques azotés et procéde pour leur préparation. |
US3133932A (en) * | 1959-05-25 | 1964-05-19 | Deere & Co | Production of 2-oxazolidinones |
DE1198368B (de) * | 1959-08-06 | 1965-08-12 | Robins Co Inc A H | Verfahren zur Herstellung von 5-(2, 6-Dimethoxyphenoxymethyl)-oxazolidon-(2) |
DE1803180U (de) * | 1959-11-05 | 1959-12-31 | Wickmann Werke Ag | Freiluft-isolator. |
FR1274416A (fr) * | 1959-12-09 | 1961-10-27 | American Cyanamid Co | Procédé de préparation de nouvelles aryloxyméthyl-2-oxazolidinones |
US3450674A (en) * | 1963-10-04 | 1969-06-17 | Dow Chemical Co | Poly-n-heterocyclics and method |
GB1102011A (en) * | 1964-05-21 | 1968-02-07 | Richardson Merrell Spa | Phenol esters of amino acids |
NL129025C (sv) * | 1965-04-29 | |||
US3538064A (en) * | 1965-06-04 | 1970-11-03 | Commercial Solvents Corp | Acrylic acid esters of hydroxymethyl oxazolidones |
GB1224995A (en) * | 1968-09-20 | 1971-03-10 | Delalande Sa | New 5-propargyloxymethyl-2-substituted oxazolidinones and their process of preparation |
GB1222708A (en) * | 1968-10-22 | 1971-02-17 | Delalande Sa | Novel 5-(n-substituted aminomethyl)-2-oxazolidinones and their process of preparation |
ZA71932B (en) * | 1970-02-27 | 1971-10-27 | Ici Ltd | Organic compounds |
BE763964A (fr) * | 1970-03-24 | 1971-09-08 | Delalande Sa | Nouveaux derives de l'aminocarbonyl-3 oxazolidinone-2, leur procede de preparation et leur application en therapeutique |
FR2179582B1 (sv) * | 1972-04-13 | 1975-10-10 | Synthelabo |
-
1975
- 1975-08-29 DE DE2538424A patent/DE2538424C2/de not_active Expired
-
1976
- 1976-07-19 ZA ZA764279A patent/ZA764279B/xx unknown
- 1976-07-20 IE IE1601/76A patent/IE43396B1/en unknown
- 1976-07-21 IN IN1305/CAL/76A patent/IN144061B/en unknown
- 1976-07-21 IL IL50091A patent/IL50091A/xx unknown
- 1976-07-22 AU AU16145/76A patent/AU506441B2/en not_active Expired
- 1976-07-22 CH CH937676A patent/CH623043A5/de not_active IP Right Cessation
- 1976-08-18 CA CA259,377A patent/CA1072567A/en not_active Expired
- 1976-08-20 AT AT619876A patent/AT347453B/de not_active IP Right Cessation
- 1976-08-20 FI FI762400A patent/FI62074C/fi not_active IP Right Cessation
- 1976-08-23 GB GB34969/76A patent/GB1555658A/en not_active Expired
- 1976-08-25 NO NO762928A patent/NO143316C/no unknown
- 1976-08-25 LU LU75659A patent/LU75659A1/xx unknown
- 1976-08-25 SE SE7609426A patent/SE424991B/sv unknown
- 1976-08-27 HU HU76NO208A patent/HU174488B/hu unknown
- 1976-08-27 DK DK387876A patent/DK387876A/da not_active Application Discontinuation
- 1976-08-27 FR FR7626017A patent/FR2321884A1/fr active Granted
- 1976-08-27 NL NL7609559A patent/NL7609559A/xx not_active Application Discontinuation
- 1976-08-27 BE BE2055273A patent/BE845581A/xx not_active IP Right Cessation
- 1976-08-28 PL PL1976192074A patent/PL100901B1/pl unknown
- 1976-08-28 JP JP51102221A patent/JPS5253857A/ja active Granted
- 1976-08-30 US US05/718,610 patent/US4139538A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE2538424A1 (de) | 1977-03-03 |
IE43396B1 (en) | 1981-02-11 |
DK387876A (da) | 1977-03-01 |
CH623043A5 (sv) | 1981-05-15 |
SE7609426L (sv) | 1977-03-01 |
FR2321884A1 (fr) | 1977-03-25 |
US4139538A (en) | 1979-02-13 |
FR2321884B1 (sv) | 1979-03-23 |
IL50091A0 (en) | 1976-09-30 |
LU75659A1 (sv) | 1977-03-31 |
NO143316B (no) | 1980-10-06 |
AU506441B2 (en) | 1980-01-03 |
GB1555658A (en) | 1979-11-14 |
JPS564554B2 (sv) | 1981-01-30 |
CA1072567A (en) | 1980-02-26 |
ATA619876A (de) | 1978-05-15 |
ZA764279B (en) | 1977-07-27 |
JPS5253857A (en) | 1977-04-30 |
IE43396L (en) | 1977-02-28 |
NO762928L (sv) | 1977-03-01 |
FI762400A (sv) | 1977-03-01 |
BE845581A (fr) | 1976-12-16 |
DE2538424C2 (de) | 1983-01-05 |
AT347453B (de) | 1978-12-27 |
FI62074C (fi) | 1982-11-10 |
PL100901B1 (pl) | 1978-11-30 |
NO143316C (no) | 1981-01-14 |
IN144061B (sv) | 1978-03-18 |
NL7609559A (nl) | 1977-03-02 |
HU174488B (hu) | 1980-01-28 |
AU1614576A (en) | 1978-01-26 |
IL50091A (en) | 1981-01-30 |
FI62074B (fi) | 1982-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE432247B (sv) | Sett att framstella dihydro-cyklosporin c | |
SE433222B (sv) | Sett att framstella modifierad polysackarid | |
SE430502B (sv) | Sett att framstella nya substituerade imidazolidiner | |
SE436425B (sv) | Sett att framstella nya spirolaktoner | |
SE422077B (sv) | Sett att framstella syntesgas | |
SE441528B (sv) | Sett att framstella nya 3-kinolin-karboxylsyraderivat | |
SE7600277L (sv) | Sett att framstella sampolymerisatpulver | |
SE7606280L (sv) | Sett att framstella etrar | |
SE7607152L (sv) | Sett att framstella nya 2-piperidinoalkyl-1,4-bensdioxaner | |
SE435928B (sv) | Sett att framstella nya 3-aryl-oxazolidin-2-oner | |
SE420728B (sv) | Sett att framstella piperazinyliminorifamyciner | |
SE425736B (sv) | Sett att framstella kromanon-(4) | |
SE427111B (sv) | Sett att framstella pilokarpiniumsalter | |
SE7602729L (sv) | Sett att framstella nya indolylalkylpiperidiner | |
SE424991B (sv) | Sett att framstella nya 5-fenyl-oxazolidinoner | |
SE434842B (sv) | Sett att framstella nya 7-amino-tiazolyl-acetamido-cefalosporansyraderivat | |
SE7705986L (sv) | Sett att framstella nya aryltrifluoretyaminer | |
SE430156B (sv) | Sett att framstella 2-subst-1-(omega-aminoalkoxi)-bensener | |
SE7601927L (sv) | Nya isocyanater och sett att framstella dessa | |
SE428930B (sv) | Sett att framstella nya depa-stereoidestrar tillhorande ostran-serien | |
SE425390B (sv) | Sett att framstella nya 11-oxo-prostaglandinderivat | |
SE7607171L (sv) | Sett att framstella indolokinoliziner | |
SE412233B (sv) | Sett att framstella nya fenotiazinderivat | |
SE420690B (sv) | Sett att kontinuerligt framstella vermeisolerande ledningsror | |
SE7509209L (sv) | Sett att framstella nya kinolinderivat |